Skip to main content
The air liquide group

The Air Liquide Group

The world leader in gases, technologies and services for Industry and Health, Air Liquide is present in 80 countries with approximately 68,000 employees and serves more than 3 million customers and patients.


Oxygen, nitrogen and hydrogen have been at the core of the company’s activities since its creation in 1902. Air Liquide’s ambition is to be the leader in its industry, delivering long-term performance and acting responsibly. Air Liquide ideas create value over the long term. At the core of the company’s development are the commitment and constant inventiveness of its people. Air Liquide anticipates the challenges of its markets, invests locally and globally, and delivers high-quality solutions to its customers and patients, and the scientific community. The company relies on competitiveness in its operations, targeted investments in growing markets and innovation to deliver profitable growth over the long-term. Air Liquide’s revenues amounted to €16.4 billion in 2015, and its solutions that protect life and the environment represented more than 40% of sales. On May 23, 2016, Air Liquide completed its acquisition of Airgas, which had revenues amounting to $5.3 billion (around €4.8 billion) for the fiscal year ending March 31, 2016. Airliquide serves 5 business lines including Industry, Healthcare, Electronics, Engineering & Construction, and Science and New Energies. 

Air Liquide is listed on the Paris Euronext stock exchange (compartment A) and is a member of the CAC 40 and Dow Jones Euro Stoxx 50 indexes.

Air Liquide Group

Air Liquide Healthcare

Air Liquide Healthcare is the second largest business line in the Air Liquide group. It offers products and services in the hospital and at home in the following 4 domains:

  • Home Healthcare
  • Hospital Care 
  • Hygiene
  • Healthcare Specialty Ingredients

Air liquide Healthcare is especially a pioneer and leader in home healthcare, taking care of 1.4 million patients suffering from chronic diseases at home. ALH provides its patients with unparalleled care from diagnosis to education to ongoing support and intervention by trained nurses and technicians. Air Liquide Healthcare specifically focuses on the treatment of chronic diseases such as Chronic Obstuctive Pulmonary Disease, Obstuctive Sleep Apnea, and Chronic Respiratory Failure. It also supports drug administration at home to manage diseases such as diabetes, pulmonary arterial hypertension, and pain. 

Air Liquide Healthcare continues to maintain a strong committment to protect and meet it's patients' needs and support first and foremost. 

Air Liquide Healthcare

Air Liquide in numbers

€20,349 M

2017 Group Revenue



3.5+ million

Customers and Patients